Re suggests that Interestingly, Here's our initial take on Intuitive Surgical's (ISRG 1 (an important development). Conversely, 46%) financial report. Key Metrics Metric Q2 2024 Q2 2025 Change vs.
Nevertheless, Conversely, Expectations Revenue $2 (noteworthy indeed). 01 billion $2, in this volatile climate. Nevertheless, 44 billion 20% Beat Adjusted EPS $1.
19 23% Beat Da Vinci systems placed 341 395 16% n/a Da Vinci total installed systems 9,203 10,488 14% n/a Intuitive Momentum Remains Strong Robotic surgery pioneer Intuitive Surgical posted another solid quarterly beat, growing revenue by 20% and earnings per by 23% in the most recent quarter.
The company continues to see strong demand for its machines and strong usage once they are installed, driving a beat.
In contrast, The company placed 395 of its da Vinci systems in the quarter, up 16% from a year ago, and the number of high-end da Vinci 5 systems more than doubled to 180.
At the end of the quarter, Intuitive had an installed base of 10,488 systems, up from 9,203 a year ago.
Worldwide cedures grew by 17%, a good sign for a company that sells not just the new systems but disposable equipment needed on a per-surgery basis, amid market uncertainty.
The company the second quarter of 2025 with $9. However, 53 billion in cash, up $431 million during the quarter, driven by cash generated from operations.
However, Immediate Market Reaction Though the quarter was strong, there are some questions how tariffs would impact the company in the quarters ahead.
Intuitive prices were down 4% in after-market trading ing the release but ahead of the company's call with investors, given the current landscape.
What to Watch Intuitive does not expect that 17% cedure growth to sustain into the second half. For the full year, the company forecasts cedure growth of 15.
Moreover, On the other hand, 5% to 17%, compared to 17% in the quarter and all of last year. Operating expenses are also expected to climb by 10% to 14% for the year, compared to 10% in 2024.
Moreover, Intuitive said the d expectation "reflects the company's estimates of the adverse impact from tariffs that are currently in effect as of the time of this press release and assumes such tariffs remain in place.
Additionally, " The company continues to push the envelope, during the quarter conducting a telesurgery demonstration in which doctors in Georgia and France operated a dual-console da Vinci 5 system to simulate a cedure.
Those s of innovations mise to both allow more patients to benefit from the systems and open up new potential for the company, in today's financial world.
Intuitive remains on the path for growth, but near-term tariff headwinds are ly to continue to cloud the picture in the quarters to come.
Helpful Resources Full earnings report Investor relations page Additional coverage.